Evidence map›Paper›PMID 19338077›Full record

ArticleNature genetics2009

Somatic and germline genetics at the JAK2 locus.

Peter J Campbell

Abstract readComment
PubMed Publisher
In one paragraph

Article in Nature genetics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. The Contribution ofInternational journal of molecular sciences · 2022
    Review
  6. Recent advances in hydrogels-based osteosarcoma therapy.Frontiers in bioengineering and biotechnology · 2022
    Review
  7. Germline Variants That Affect Tumor Progression.Trends in genetics : TIG · 2021
    Review
  8. Late-Onset Chorea inMovement disorders clinical practice · 2021
    Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Myelofibrosis 2012: it's complicated.Therapeutic advances in hematology · 2012
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Peter J CampbellWellcome Trust Sanger Institute, Hinxton, UK. pc8@sanger.ac.uk
Wellcome Sanger Institute · GB

Funding

Wellcome Trust 088340
6 · The paper itself

Abstract

Myeloproliferative neoplasms are hematological malignancies frequently associated with somatically acquired mutation of the JAK2 gene. A new study shows that these mutations are preferentially found within a particular inherited JAK2 haplotype, implying the existence of a strong, but uncharacterized, interaction between somatic and germline genetics at this locus.

Indexed as

Germ-Line MutationChromosome MappingHaplotypesHematologic NeoplasmsHumansJanus Kinase 2JAK2 protein, humanJanus Kinase 2

Identifiers

PMID19338077
OpenAlexW1575389553

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.